Skip to content

Clinical trials

Terminated Phase 3 Bipolar Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Phase: Phase 3 Status: Terminated Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20041
20061
20073
20081
20103
20111
20122
20141
20161
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lindner Center of HOPE3
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.3
Takeda2
University Hospitals Cleveland Medical Center2
AstraZeneca1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Massachusetts General Hospital1
Mclean Hospital1
National Institute of Mental Health (NIMH)1
Northwestern University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder18
Metabolic Syndrome2
Psychotic Disorders2
Schizophrenia2
Depression, Postpartum1
Major Depressive Disorder1
Parasomnias1
Sexual Dysfunction, Physiological1
Sleep Initiation and Maintenance Disorders1

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.